About 283 million people worldwide suffer from alcohol use disorder, a debilitating health challenge for which limited therapeutic options are available. The cost to society is estimated at greater than $2 trillion annually.
Dren Bio and Novartis to develop bispecific antibodies for cancer
The bispecific antibodies are intended for cancer treatment. Credit: Aunt Spray / Shutterstock. Dren Bio has partnered strategically with Novartis subsidiary Novartis Pharma to discover